BUYINS.NET: GLAD, HAYN, HSWI, HWCC, IAAC, IDRA Have Also Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days

Jul 28, 2008 (M2 PRESSWIRE via COMTEX) -- IAAC | Quote | Chart | News | PowerRating -- BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold list for 13 consecutive trading days: Gladstone Capital Corp. (NASDAQ: GLAD), Haynes International Inc. (NASDAQ: HAYN), HSW International Inc. (NASDAQ: HSWI), Houston Wire & Cable Company (NASDAQ: HWCC), International Assets Holding Corp. (NASDAQ: IAAC), Idera Pharmaceuticals Inc. (NASDAQ: IDRA). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer's total shares outstanding. Regulation SHO mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.

Gladstone Capital Corp. (NASDAQ: GLAD | Quote | Chart | News | PowerRating) offers loans services. The company specializes in debt security investments in small and medium sized companies. It typically, uses the investment for the initial acquisition of portfolio companies, add-on acquisitions, recapitalization including cash-outs, senior debt reduction, and for short-term bridge financing. The firm invests in the form of loans with varying levels of current coupon and return enhancement in the form of senior term loans, senior subordinated loans, and junior subordinated loans between $3 million and $15 million and can be repaid over five years. Junior subordinated loans vary from $3 million to $15 million in size for a term of more than five years and require equity participation. Senior terms loans vary from $1 million to $ 5million in size and can be repaid over five years. These loans require a first lien on assets as collateral. Senior subordinated loans vary from $3 million to $15 million in size and require a second lien on assets as collateral. The firm does not invest in technology, financial services, real estate, and oil and gas sectors. It invests in companies generating revenues between $20 million and $500 million in private businesses that are substantially owned by leveraged buyout funds, venture capital funds, or family owned businesses. It does not sponsor turnaround situations; however, the firm can consider standalone companies or situations, where the contemplated transaction relieves an otherwise attractive company from an unworkable capital structure. Gladstone Capital Corp. was founded in 2001 and is headquartered in McLean, Virginia with additional offices across United States. With 21.09 million shares outstanding and 2.2 million shares declared short as of July 2008, the failure to deliver in shares of GLAD has not been resolved and a buy-in is imminent. According to quarterly data provided by the SEC, there were still 21,305 shares of GLAD that were failing-to-deliver as of September 28, 2007.

Haynes International Inc. (NASDAQ: HAYN | Quote | Chart | News | PowerRating) and its subsidiaries develop, manufacture, market, and distribute high-performance nickel-and cobalt-based alloys primarily for use in the aerospace, land-based gas turbine, and chemical processing industries. The company's products include high-temperature resistant alloys (HTA) and corrosion resistant alloys (CRA). Its HTA products are used by manufacturers of equipment that is subjected to high temperatures, such as jet engines for the aerospace industry, gas turbine engines for power generation, waste incineration, and industrial heating equipment. Haynes International's CRA products are used in applications that require resistance to corrosion, such as chemical processing, power plant emissions control, and hazardous waste treatment. The company produces its alloys primarily in sheet, coil, and plate forms; seamless and welded tubular forms; and bar, billets, and wire forms. It sells its products primarily in the United States, Europe, Asia, and India. The company was founded in 1912 and is headquartered in Kokomo, Indiana. With 11.91 million shares outstanding and 2.12 million shares declared short as of July 2008, the failure to deliver in shares of HAYN has not been resolved and a buy-in is imminent. According to quarterly data provided by the SEC, there were still 23,387 shares of HAYN that were failing-to-deliver as of August 15, 2007.

HSW International Inc. (NASDAQ: HSWI | Quote | Chart | News | PowerRating) an online publishing company, develops and operates Internet businesses that are focused on providing consumers with digital content database. It primarily focuses on the online publishing of localized and translated Chinese and Brazilian editions of the HSW Internet site. The company operates a Brazilian Internet Web site, hsw.uol.com.br, which has approximately 3,500 articles, including articles from the HSW content database translated from English to Portuguese, and originally created content in Portuguese. In addition, it plans to offer a library of digital content, including originally authored content and the content acquired from third parties for the company's use and for licensing to various customers. The company was founded in 2006 and is headquartered in Atlanta, Georgia. With 53.61 million shares outstanding and 1.79 million shares declared short as of July 2008, the failure to deliver in shares of HSWI has not been resolved and a buy-in is imminent.

Houston Wire & Cable Company (NASDAQ: HWCC | Quote | Chart | News | PowerRating) through its subsidiaries, distributes specialty wire and cable products in the United States. It offers continuous and interlocked armor cables, control and power cables, electronic wire and cables, flexible and portable cords, instrumentation and thermocouple cables, lead and high temperature cables, medium voltage cables, and premise and category wire and cables. The company also provides private branded products, which include LifeGuard, DataGuard, and Houwire cables. It serves communications, energy, engineering and construction, general manufacturing, infrastructure, petrochemical, transportation, utility and wastewater treatment industries. Houston Wire & Cable Company was founded in 1975 and is headquartered in Houston, Texas. With 17.79 million shares outstanding and 2.92 million shares declared short as of July 2008, the failure to deliver in shares of HWCC has not been resolved and a buy-in is imminent. According to quarterly data provided by the SEC, there were still 23,668 shares of HWCC that were failing-to-deliver as of September 27, 2007.

International Assets Holding Corp. (NASDAQ: IAAC | Quote | Chart | News | PowerRating) through its subsidiaries, provides various financial services to investment banks, commercial banks, brokers, institutional investors, corporations, charities, and governmental organizations worldwide. Its International Equities Market-Making segment acts as a wholesale market maker in select foreign securities, including unlisted American depository receipts and foreign ordinary shares. It also provides execution services and liquidity to national broker-dealers, regional broker-dealers, and institutional investors. The company's International Debt Capital Markets segment trades various international debt instruments, such as investment grade and emerging market bonds that trade on an over-the-counter basis. It also arranges, structures, and distributes international debt transactions, which include bond issues, syndicated loans, and asset-backed securitizations, as well as forms of other negotiable debt instruments for issuers located primarily in emerging markets. International Assets Holding's Foreign Exchange Trading segment trades illiquid currencies of developing countries; executes trades based on the foreign currency flows; and acts as a principal in buying and selling foreign currencies on a spot basis. Its customers include financial institutions, multi-national corporations, and governmental and charitable organizations operating in developing countries. The company's Commodities Trading segment provides a range of trading and hedging capabilities to select producers, consumers, recyclers, and investors in precious metals and certain base metals. Its Asset Management segment manages third party assets and investment gains or losses on the company's investments in registered funds or proprietary accounts managed either by the company's investment managers or by independent investment managers. The company was founded in 1987 and is based in Altamonte Springs, Florida. With 8.56 million shares outstanding and 185,700 shares declared short as of July 2008, the failure to deliver in shares of IAAC has not been resolved and a buy-in is imminent. According to quarterly data provided by the SEC, there were still 24,683 shares of IAAC that were failing-to-deliver as of September 19, 2007.

Idera Pharmaceuticals Inc. (NASDAQ: IDRA | Quote | Chart | News | PowerRating) a biotechnology company, engages in the discovery and development of DNA- and RNA-based compounds for the treatment of infectious diseases, autoimmune diseases, cancer, and asthma and allergies and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for infectious diseases, including hepatitis C virus infection. The company's infectious disease program also includes evaluation of RNA-based compounds that act as agonists of TLR7 and TLR8, which are stabilized immune modulatory RNA (SIMRA) compounds. Idera Pharmaceuticals has also identified DNA-based compounds that act as antagonists of TLR7 and TLR9 for the treatment of autoimmune diseases, such as lupus and rheumatoid arthritis. Its cancer treatment research program is focused on SIMRA agonists of TLR7 and TLR8. The company has a license agreement with Merck KGaA to research, develop, and commercialize products containing its TLR9 agonists, including IMO-2055 and IMO-2125 for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer's disease; and a research collaboration and option agreement, as well as a separate license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. Idera Pharmaceuticals was founded in 1989 and is based in Cambridge, Massachusetts. With 22.39 million shares outstanding and 1.02 million shares declared short as of July 2008, the failure to deliver in shares of IDRA has not been resolved and a buy-in is imminent.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index